SOX4: The unappreciated oncogene

Carlos S Moreno1

  • 1Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Whitehead Bldg, Rm 105J, 615 Michael St. Atlanta, GA, USA.

Insights

SOX4 is a key developmental factor that drives cancer progression by promoting cell survival and metastasis. Targeting SOX4 is crucial for future cancer research and developing new therapies.

Area of Science:

  • Molecular Biology
  • Developmental Biology
  • Cancer Research

Background:

  • SOX4 is a crucial transcription factor regulating stemness and developmental pathways.
  • SOX4 gene amplification and overexpression are observed in over 20 malignancies, implicating it as an oncogene.
  • SOX4 hyperactivity promotes cell survival, stemness, epithelial-mesenchymal transition, migration, and metastasis.

Purpose of the Study:

  • To investigate the role of SOX4 as an oncogene in various malignancies.
  • To understand the regulatory mechanisms of SOX4 overexpression.
  • To explore the common downstream effects of SOX4 hyperactivity.

Main Methods:

  • Analysis of SOX4 gene amplification and expression levels in cancer.
  • Investigating the regulation of SOX4 by PI3K, Wnt, and TGFβ signaling pathways.
  • Studying the interaction of SOX4 with other transcription factors.
  • Assessing the impact of SOX4 hyperactivity on cellular processes like stemness and migration.

Main Results:

  • SOX4 is frequently amplified and overexpressed in numerous cancer types.
  • SOX4 overexpression is linked to activation of PI3K, Wnt, and TGFβ pathways.
  • SOX4 hyperactivity consistently promotes cell survival, stemness, EMT, migration, and metastasis.
  • SOX4's effects are context-specific due to interactions with other transcription factors.

Conclusions:

  • SOX4 acts as a potent oncogene, driving key processes essential for cancer progression.
  • Understanding SOX4 regulation and function is vital for cancer therapy.
  • Targeting SOX4 presents a significant challenge and opportunity for future cancer drug development.